User:Gdellios/sandbox

Type	S.A. Corporation Traded as	Euronext: COX Industry	Pharmaceuticals Founded	1996 Headquarters	Sophia Antipolis, France Key people	Michele Garufi (Co-founder, Chairman and CEO) Marketed products	AdenoPlus, Xailin, Zared R&D candidates	Vesneo, AC-170, AC-155, AzaSite, BromSite, Xailin Viral. Revenue	 €6.0 million (2014) Market Cap	 €207.5 million (2014) Cash Position	 €32.9 million (2014) Number of employees	125 (2015) Subsidiaries	Nicox Ophthalmics, Inc. (US), Nicox Pharma (Europe), Doliage (France), Nicox Farma (Italy) Websites	www.nicox.com (Corporate) www.nicox.co.uk (Local UK) www.nicox.es (Local Spain)